Nurocor Clinical Platform AI is now available
Nurocor Clinical Platform AI is now available.
A major milestone for Nurocor – our Nurocor Clinical Platform AI is now available. This release represents a major step forward in our vision to transform clinical development from document driven processes to intelligent, structured, AI-enabled workflows.
At the center is Ask Dan, our conversational interface connecting users with context-aware AI agents across Study Designer, Study and Protocol Elements, and Schedule of Activities applications. Ask Dan acts as a “digital subject matter expert” analyzing, suggesting improvements and updating study designs in collaboration with study design teams.
This release also introduces AI-assisted protocol ingestion from both traditional documents and structured USDM data, turning protocol content into information that can be understood, queried, and acted upon. Secure external access to agents in support of advanced agent-to-agent workflows, AI-enabled study creation, intelligent authoring assistance, AI assistants to accelerate standards management, and additional agentic capabilities across the clinical development lifecycle are coming.
This is more than adding AI to Nurocor Clinical platform. It is about creating an AI-native clinical development environment where protocol data becomes computable, connected, and actionable from study design through execution.
#DPharm #ClinicalTrials #ClinicalDevelopment #ArtificialIntelligence #AgenticAI #DigitalProtocol #USDM #ICHM11 #ClinicalResearch #LifeSciences #Nurocor #AI
